Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease
Pharmaceuticals · 27.09.2024 · 17 (10) · 1279
DOI: 10.3390/ph17101279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 27.09.2024. Verfasst von Eleni Gavriilaki und 18 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Department and Bone Marrow Transplant (BMT) Unit, G. Papanicolaou Hospital, 57010 Thessaloniki, Greece. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Despite novel biological agents, steroid-dependent or -refractory graft-versus-host disease (GvHD) remains a severe complication of allogeneic hematopoietic cell transplantation (allo-HCT). Extracorporeal photopheresis (ECP) is an alternative, non-immunosuppressive treatment for patients with acute (aGvHD) or chronic (cGvHD) GvHD. The aim of this study was to investigate the safety and efficacy of ECP in the treatment of acute and chronic GvHD; Methods: We prospectively studied 112 patients with cGvHD who received one or more previous lines of treatment and 28 patients with steroid-dependent or refractory grade II-IV aGvHD post-alloHSCT.
Results
In terms of severe aGvHD, most of the patients (19/28) responded to ECP treatment, while the five-year overall survival (OS) was 34%. After adjustment for several confounder factors, the reduction in immunosuppression (p = 0.026) and number of ECP sessions (p < 0.001) were associated with improved OS. Regarding chronic GvHD, only 19 patients failed to respond to ECP treatment; though significantly lower rates of response were presented in patients with visceral involvement (p = 0.037) and earlier post-transplant GVHD diagnosis (p = 0.001). Over a follow-up period of 45.2 [interquartile range (IQR): 5.6–345.1] months, the 5-year cumulative incidence (CI) of cGvHD-related mortality was 21.2% and was significantly reduced in patients with ECP response (p < 0.001), while the 5-year OS was 65.3%.
Conclusions
Our results confirm the safety and efficacy of ECP in patients with GvHD and provide sufficient data for further investigation and the best combination drugs needed such that GvHD will not be the major barrier of allo-HCT in the near future.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematology Department and Bone Marrow Transplant (BMT) Unit, G. Papanicolaou Hospital, 57010 Thessaloniki, Greece.
- Second Propedeutic Department of Internal Medicine, Hippocration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece.
- Medical School, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.
ORCID-Profile: Eleni Gavriilaki, Andriana Lazaridou, Paschalis Evangelidis, Anna Papakonstantinou, Zoi Bousiou
Zitieren
APA
Gavriilaki, E., Papchianou, E., Karavalakis, G., Batsis, I., Panteliadou, A., Lazaridou, A., Mallouri, D., Constantinou, V., Karvouni, P., Evangelidis, P., Papakonstantinou, A., Papalexandri, A., Kaloyannidis, P., Spyridis, N., Bousiou, Z., Vardi, A., Yannaki, E., Sotiropoulos, D., & Sakellari, I. (2024). Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease. Pharmaceuticals, 17(10), 1279. https://doi.org/10.3390/ph17101279
Vancouver
Gavriilaki E, Papchianou E, Karavalakis G, Batsis I, Panteliadou A, Lazaridou A, et al. Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease. Pharmaceuticals. 2024;17(10):1279. doi:10.3390/ph17101279
BibTeX
@article{Gavriilaki2024,
author = {Gavriilaki, Eleni and Papchianou, Eleni and Karavalakis, Giorgos and Batsis, Ioannis and Panteliadou, Alkistis and Lazaridou, Andriana and Mallouri, Despina and Constantinou, Varnavas and Karvouni, Paraskevi and Evangelidis, Paschalis and Papakonstantinou, Anna and Papalexandri, Apostolia and Kaloyannidis, Panayotis and Spyridis, Nikolaos and Bousiou, Zoi and Vardi, Anna and Yannaki, Evangelia and Sotiropoulos, Damianos and Sakellari, Ioanna},
title = {Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {10},
pages = {1279},
doi = {10.3390/ph17101279}
}
EUVIMED